SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549
--------------------------------------------------------------------------------

                                   FORM 10-QSB
(Mark One)
/ X /    ANNUAL  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
         EXCHANGE ACT OF 1934
For the quarter ended December 31, 2000.
                                       OR

/   /    TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
         EXCHANGE  ACT  OF  1934
For the transition period from ________ to _________

                     Commission file number  33-96882-LA
                                             -----------

                       CARING PRODUCTS INTERNATIONAL, INC.
                 (Name of small business issuer in its charter)
                              ____________________

           DELAWARE                                       98-0134875
(State or other jurisdiction of                (IRS Employer Identification No.)
incorporation or organization)            ____________________


                     PO BOX 9288,  SEATTLE, WASHINGTON 98109
                           (principal mailing address)

                                 (206) 853-1131
                (Issuer's telephone number, including area code)
                              ____________________

     Securities registered under Section 12(b) of the Exchange Act:      None.

     Securities registered under Section 12(g) of the Exchange Act:
               Common Stock, $.01 par value
               Warrants to purchase common stock.

Check  whether the issuer: (1) filed all reports required to be filed by Section
13  or 15 (d) of the Exchange Act during the past 12 months (or for such shorter
period  that the registrant was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.
Yes  X      No
    ---        ---

Check  if there is no disclosure of delinquent filers in response to Item 405 of
Regulation  S-B  contained in this form, and no disclosure will be contained, to
the  best  of  registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  by  reference  in Part III of this Form 10-QSB.  / X /

                   ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                           DURING THE PAST FIVE YEARS
     Not applicable.
                    APPLICABLE ONLY TO CORPORATE REGISTRANTS

     State  the  number of shares outstanding of each of the issuer's classes of
common  equity,  as of  January 31, 2001: 3,056,343 shares of common stock, $.01
par  value  (the  "Common  Stock").

     Transitional  Small  Business  Disclosure  Format  (check  one):
Yes        No   X
    ---        ---
                       DOCUMENTS INCORPORATED BY REFERENCE

Part III - Certain exhibits                    Included in prior filings made
Listed in response to Item 13(a)               under the Securities Act of 1933.


1
<PAGE>
<TABLE>
<CAPTION>
                         CARING PRODUCTS INTERNATIONAL, INC
                                    FORM 10-QSB
                       FOR THE PERIOD ENDED DECEMBER 31, 2000


     INDEX                                                                PAGE NUMBER


PART I:    FINANCIAL  INFORMATION


     Item 1 Financial Statements
<S>                                                                               <C>
            Consolidated Balance Sheets at March 31, 2000 and December 31, 2000     3
                  (unaudited for December 31, 2000 period)

            Consolidated Statements of Operations for the three and nine-month
            periods ended December 31, 1999 and December 31,  2000                  4
                  (unaudited)

            Consolidated Statements of Cash Flows for the nine-month
            periods ended December 31, 1999 and December 31, 2000                   5
                  (unaudited)

            Notes to Unaudited Consolidated Financial Statements                    6


     Item 2 Managements Discussion and Analysis of
                  Financial Condition and Results of Operations                     7


PART II     OTHER INFORMATION                                                       9
</TABLE>


2
<PAGE>
<TABLE>
<CAPTION>
                   CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                                CONSOLIDATED BALANCE SHEETS



                                   ASSETS
                                                                                DECEMBER 31,
                                                                  MARCH 31,        2000
                                                                    2000        (UNAUDITED)
                                                               --------------  -------------
<S>                                                            <C>             <C>
Current Assets
  Cash                                                         $     181,763   $     13,326
  Accounts receivable less allowance
     of $3,026 at March 31, 2000 and $0 at December 31, 2000          57,498            526
  Inventories                                                         15,715              -
  Prepaid expenses                                                    24,091          1,024
                                                               --------------  -------------

          Total current assets                                       279,067         14,876

  Equipment, net                                                      20,338              -
                                                               --------------  -------------

                                                               $     299,405   $     14,876
                                                               --------------  -------------


            LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current Liabilities
  Accounts payable                                             $     107,945   $    111,641
  Accrued expenses                                                    24,621         37,500
                                                               --------------  -------------

          Total current liabilities                                  132,566        149,141

Stockholders' equity (deficit)
  Preferred stock, par value $0.01 per share; authorized,
    1,000,000 shares; none outstanding                                     -              -
  Common stock, par value $0.01 per share; authorized,
    15,000,000 shares; issued and outstanding, 3,056,343
    in March 31, 2000 and December 31, 2000 respectively              30,564         30,564
  Additional paid-in capital                                      19,232,069     19,232,069
  Accumulated deficit                                            (19,095,794)   (19,396,898)
                                                               --------------  -------------

          Total stockholders' equity (deficit)                       166,839       (134,265)
                                                               --------------  -------------

                                                               $     299,405   $     14,876
                                                               --------------  -------------
</TABLE>


           See accompanying notes to consolidated financial statements


3
<PAGE>
<TABLE>
<CAPTION>
                    CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                          CONSOLIDATED STATEMENTS OF OPERATIONS
                      THREE AND NINE MONTH PERIODS ENDED DECEMBER 31, 1999 AND 2000
                                           (UNAUDITED)


                                     THREE MONTH PERIODS        NINE MONTH PERIODS
                                      ENDED DECEMBER 31,        ENDED DECEMBER 31,
                                      1999         2000         1999         2000
                                   -----------  -----------  -----------  -----------
<S>                                <C>          <C>          <C>          <C>
Revenues                           $  111,471   $   15,135   $  395,587   $   99,535
Cost of sales                          57,790        2,200      174,017       11,535
                                   -----------  -----------  -----------  -----------

        Gross profit                   53,681       12,935      221,570       88,000

Operating expenses
  Selling                              81,614       20,808      198,801       61,004
  General and administrative          192,216       63,698      668,480      333,856
  Amortization and depreciation         8,761       15,484       41,884       20,338
                                   -----------  -----------  -----------  -----------

        Total operating expenses      282,591       99,990      909,165      415,198
                                   -----------  -----------  -----------  -----------

        Loss from operations         (228,910)     (87,055)    (687,595)    (327,198)

Other income (expense)
  Other income                        (23,629)           -      180,795       26,094
  Interest expense                          -            -         (741)           -
  Loss on sale of assets                    -            -      (84,176)           -
                                   -----------  -----------  -----------  -----------

                                      (23,629)           -       95,878       26,094
                                   -----------  -----------  -----------  -----------

        Net loss                   $ (252,539)  $  (87,055)  $ (591,717)  $ (301,104)
                                   -----------  -----------  -----------  -----------


  Weighted average common shares    3,056,343    3,056,343    3,056,343    3,056,343
                                   ===========  ===========  ===========  ===========
    outstanding

  Net loss per common share,       $    (0.08)  $    (0.03)  $    (0.19)  $    (0.10)
                                   ===========  ===========  ===========  ===========
    primary and dilutive
</TABLE>


           See accompanying notes to consolidated financial statements


4
<PAGE>
<TABLE>
<CAPTION>
             CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                   CONSOLIDATED STATEMENTS OF CASH FLOWS
             NINE MONTH PERIODS ENDED DECEMBER 31, 1999 AND 2000
                                 (UNAUDITED)


Increase (Decrease) in Cash                                  1999        2000
                                                          ----------  ----------
<S>                                                       <C>         <C>
Cash flows from operating activities
  Net loss                                                $(591,717)  $(301,104)
  Adjustments to reconcile net loss to net cash
    used in operating activities
    Amortization and depreciation                            41,884      20,338
    Issuance of restricted common stock to employees         55,000           -
    Loss from disposal of equipment                          84,176           -
    Change in allowance for doubtul accounts                124,222           -
    Discounted accounts payable                             (37,630)          -
    Changes in operating assets and liabilities
      Accounts receivable                                   206,814      56,972
      Inventories                                           351,201      15,715
      Prepaid expenses                                       15,674      23,067
      Other assets                                           18,041           -
      Accounts payable                                     (177,253)      3,696
      Accrued liabilities                                    (4,852)     12,879
      Customer deposits                                    (189,904)          -
                                                          ----------  ----------
        Net cash used in operating activities              (104,344)   (168,437)

Cash flows from investing activities
  Proceeds from sale of equipment                             1,351           -
                                                          ----------  ----------
        Net cash provided by investing activities             1,351           -

Cash flows from financing activities
  Proceeds from sale of Creative Products stock              19,200           -
  Cash contributed to Creative Products                    (369,200)          -
                                                          ----------  ----------
        Net cash used in investing activities              (350,000)          -


Decrease in cash                                           (452,993)   (168,437)

Cash at beginning of period                                 707,847     181,763
                                                          ----------  ----------

Cash at end of period                                     $ 254,854   $  13,326
                                                          ==========  ==========


Noncash investing and financing activities:
  Net book value of assets spun off to Creative Products  $ 151,866   $       -
                                                          ==========  ==========
</TABLE>


           See accompanying notes to consolidated financial statements


5
<PAGE>
                       CARING PRODUCTS INTERNATIONAL, INC.
                                AND SUBSIDIARIES
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
         NINE MONTH PERIOD ENDED DECEMBER 31, 1999 AND DECEMBER 31, 2000



NOTE  1  -  FINANCIAL  STATEMENTS

The  unaudited consolidated financial statements and related notes are presented
as  permitted  by Form 10-QSB and do not contain certain information included in
the Company's audited consolidated financial statements and notes for the fiscal
year  ended  March 31, 2000.  The information furnished reflects, in the opinion
of  management,  all  adjustments,  consisting  of  normal  recurring  accruals,
necessary  for  a  fair  presentation  of  the  results  of  the interim periods
presented.  The results of operation for the interim periods are not necessarily
indicative of the results to be expected for the entire fiscal year ending March
31,  2001.  The  accompanying  unaudited  consolidated  financial statements and
related  notes  should  be  read  in  conjunction  with the audited consolidated
financial  statements and the Form 10-KSB of Caring Products International, Inc.
and  its  subsidiaries  (the  "Company")  and notes thereto, for its fiscal year
ended  March  31,  2000.

NOTE  2  -  LOSS  PER  COMMON  SHARE

The  Company  accounts  for  loss  per common share under Statement of Financial
Accounting  Standards  No  128, "Earnings Per Share" which established standards
for computing and presenting earnings per share.  Loss per share is based on the
weighted  average  number  of  common  shares outstanding during each period and
income  available to common stockholders.  The weighted average number of common
shares  was  3,056,343  for  the three and nine-month periods ended December 31,
1999  and  December  31,  2000.  The  effect  of common equivalent shares on the
computation  of  loss  per share assuming dilution for the three and nine months
ended December 31, 1999 and December 31, 2000 was anti-dilutive and therefore is
not  included.

NOTE  3  -  INVENTORIES

Inventories  consisted of finished goods and are stated at the lower of cost, as
determined  by the first-in, first-out method, or market (net realizable value).
At  the end of Fiscal Year 2000, the Company wrote down $166,153 of inventory to
account  for  certain  products  that were held for more than a 12 month period,
products  specifically packaged for a retail chain or a specific market in which
the  Company's products are no longer in active distribution, to reflect reduced
sales  activity  from  lack  of advertising and the expectation that the Company
will  sell such inventory at substantial discounts or dispose through charitable
donations  to  hospitals or relief organizations.  The Company closed one of its
fulfillment centers on or about June 30, 2000 and expects to close the remaining
warehouses  prior  to  the  end  of  the current fiscal year. In anticipation of
closing  down the two remaining warehouses, the Company wrote down the remaining
inventory  valued  at  $4,180  during  the three months ended December 31, 2000.

NOTE  4  -  GOING  CONCERN

The  Company  incurred  a  net loss of $591,717 and $301,104 for the nine months
ended  December  31,  1999  and  2000,  respectively.  The  Company's ability to
continue  as  a  going  concern  is  contingent upon its ability to identify new
investors  for  the  Company.  The Company continues to review all its strategic
options  which  includes discussions with potential merger candidates.  There is
no  assurance  that  any  of  these  discussions  will  improve the financial or
operating  condition  of  the  Company.


6
<PAGE>
     ITEM  2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

THE  FOLLOWING  ANALYSIS OF THE RESULTS OF OPERATIONS AND FINANCIAL CONDITION OF
THE  COMPANY  SHOULD  BE  READ  IN  CONJUNCTION  WITH THE CONSOLIDATED FINANCIAL
STATEMENTS,  INCLUDING  THE NOTES THERETO, OF THE COMPANY CONTAINED ELSEWHERE IN
THIS  FORM  10-QSB.


OVERVIEW

Caring  Products  International  Inc  and  its  subsidiaries  (collectively  the
"Company" or "CPI") has designed a line of proprietary urinary incontinence pant
and  liner  products  which  have  been  sold  under  the  Rejoice  trade  name.
Historically,  the  Company's  customer  base  has been retail drug stores, home
healthcare  companies,  surgical  supply  stores  and  national  drug  wholesale
companies.  Given  the  high  costs  associated  with increasing and maintaining
distribution  for  its incontinence products at larger retail drug chain stores,
increased  competition,  and  executive  management  changes, in early 1999, the
Company  announced its intent to evaluate all of its strategic options including
licensing  the  Company's  products,  merging  with  another  company, potential
acquisitions,  obtaining  new  sources  of equity and cost-cutting measures.  As
part  of the Company's cost cutting measures, the Company ceased all operations,
advertising, marketing to maintain chain distributors, sold off remaining assets
and reduced staff.   As part of the Company's restructuring efforts, on December
23,  1999,  the  Company  spun-off its wholly-owned subsidiary Creative Products
International  Inc.  to  shareholders  of  record  on  June  30,  1999.

During  the  period  ended  December  31, 2000, the Company's sales continued to
decline  and  the Company expects that it will continue to lose money due to the
administrative  costs  of  maintaining  a  public  company  and disposing of its
remaining  inventory.  The Company closed one if its product fulfillment centers
on  or  about  June 2000, and expects to close the remaining warehouses prior to
the  end  of the current fiscal year.  The Company may close any facility at any
time.


RESULTS  OF  OPERATIONS  AND  OPERATING  EXPENSES

Revenues  decreased  from  $111,471 in the three-month period ended December 31,
1999  to  $15,135  in the comparable 2000 Period, an 86% decrease.  Revenues for
the nine-month 1999 Period was $395,587, compared to $99,535 in the 2000 Period,
a  75% decrease.  The decrease was a result of declining distribution of Rejoice
in  drug  stores,  discontinued  support  of  the brand in consumer advertising,
increased  problems for long-term consumers to find a local source of supply for
the  brand,  and  lack  of  available products sold in the quantities and styles
desired  by  consumer  healthcare  products.

Cost  of  sales decreased from $57,790 for the 1999 three month Period to $2,200
in  the  2000  Period, a decrease of 96%.   Cost of sales in the nine month 1999
period  were  $174,017,  compared to $11,535 in the 2000 period, a 94% decrease.
This  decrease is primarily attributable to reductions in sales costs associated
with  inventory  sold.  The  Company  did  not  add to its inventory through new
production  during  the  period.

For  the  three month period ended 2000, the Company generated a gross profit of
$12,935  as  compared  to  a  gross  profit  of $53,681 in the December 31, 1999
Period,  a 76% reduction.  The gross profit for the nine-month period ended 1999
was  $221,570, and $88,000 in the 2000 period, a 60% decrease. This reduction in
gross  profit  reflected  the  comparable  decrease  in  sales  activity.

Total operating expenses decreased from $282,591 in the three month December 31,
1999  Period  to  $99,990  in  the  three  month December 31, 2000 Period, a 65%
decrease.  The  operating  expenses  in the nine-month 1999 period were $909,165
and  $415,198  in  the  2000  period, a 54% decrease. This decrease reflects the
implementation  of the Company's cost cutting programs which included reductions
in  payroll,  sales  and advertising, product storage and distribution, customer
service  and  other  administration  associated with serving a national consumer
base  which  purchases  products through chain drug stores to a smaller consumer
base  which  purchases  products  through  direct mail, regional drug stores and
catalogs.

Selling  costs  decreased  75%  from  $81,614  in the three month 1999 Period to
$20,808 in the 2000 Period due to the reductions in sales and shipping expenses.
The  selling  costs  in  the  nine-month  1999 period decreased from $198,801 to
$61,004  in  the  2000  Period,  a  69%  decrease.

General  and  administrative  expenses  decreased 67% from $192,216 in the three
month  1999  Period  to  $63,698  in the 2000 Period.  Accounting and legal fees
continued  to  be  a significant portion of administration costs due to specific
filing  and  accounting requirements. The general and administrative expenses in


7
<PAGE>
the  nine-month 1999 period were $668,480 and $333,856 in the 2000 period, a 50%
decrease.  These  expenses  were  primarily  attributable  to  the  costs  of
maintaining  a  public  company  and  closing  down  its  operations.

Depreciation  and  amortization  expense  were  $8,761  in the  three month 1999
Period  and  $15,484  in  the  2000 Period.  For the nine-month 1999 period, the
depreciation  and amortization was $41,884 and $20,338 in the 2000 period, a 51%
decrease.   The  decrease was attributable to the transfer of assets to Creative
Products International Inc. which was subsequently spun-off to shareholders as a
separate  operating  company  and  the  write  off  of  certain  equipment.

The  interest expense decreased from $741 in the nine month 1999 period to $0 in
2000.  This  decrease  was  attributable  to  the  elimination  of  short-term
obligations.

Other income of $180,795 in the nine month 1999 Period was generated through the
sale  of  goods and collection of receivables written off in prior periods.  The
$26,094  of  other  income in the nine-month 2000 period was attributable to the
write  off  of  office  equipment  lease  obligations,  an  86%  decrease.

As  a  result  of  the foregoing, the Company generated a loss of $87,055 in the
three  month  2000  Period  as  compared  to  a net loss of $252,539 in the 1999
period.  The  net loss in the nine-month 1999 period was $591,717, compared to a
net  loss  of  $301,104  in  the  nine  month  2000  period.

For  the  three  and  nine  months  ended December 31, 2000 the number of shares
outstanding  remained  at  3,056,343.


LIQUIDITY  AND  CAPITAL  RESOURCES

The Company has historically financed its operations through the sale of equity.
During  the  nine-month  period  ended  December  31,  2000, the Company did not
generate  new  funding through the sale of securities, exercise of stock options
or  warrants  or  new  debt to the Company but maintained its operations through
sale  of  remaining  inventory.

As  of  December  31, 2000 the Company's principal sources of liquidity included
cash  of  $13,326  and  net  accounts  receivable  of  $526.

During the nine months ended December 31, 2000 and 1999, the Company's operating
activities  used  cash  of  $168,437 in the 2000 Period and $104,344 in the 1999
Period.   The  Company's  future  liquidity  will  be dependent on the Company's
ability  to  identify  new  investors  for  the  Company,  or obtain new sources
of  debt  or  equity.  There  is  no  assurance that the Company will be able to
generate  the  funds  needed  to  offset  its current or future obligations on a
timely  basis.  There  is  no  certainty  the  transaction  will  be  completed.


FORWARD  LOOKING  STATEMENTS

This Form 10-QSB and other reports and statements filed by the Company from time
to time with the Securities and Exchange Commission (collectively the "Filings")
contain or may contain forward-looking statements and information that are based
upon  beliefs  of,  and  information  currently  available  to,  the  Company's
management,  as  well  as  estimates  and  assumptions  made  by  the  Company's
management.

When  used  in  the  Filings,  the  words  "anticipate",  "believe", "estimate",
"expect",  "future", "intend", "plan" and similar expressions, as they relate to
the  Company  or  the Company's management, identify forward-looking statements.
Such  statements  reflect the current view of the Company with respect to future
events  and  are subject to risks, uncertainties and assumptions relating to the
Company's  operations and results of operations, competitive factors and pricing
pressures,  shifts in market demand, the performance and needs of the industries
which  constitute the customers of the Company, the costs of product development
and  other  risks and uncertainties, including, in addition to any uncertainties
with  respect  to  management  of  growth,  increases  in sales, the competitive
environment,  hiring  and  retention  of  employees,  pricing,  new  product
introductions,  product  productivity,  distribution  channels,  enforcement  of
intellectual  property  rights,  possible  volatility of stock price and general
industry  growth  and economic conditions.  Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual  results  may  differ  significantly  from  those  anticipated, believed,
estimated,  expected,  intended  or  planned.


8
<PAGE>
PART I:       FINANCIAL  INFORMATION


Item 1        Legal  Proceedings.

              None.

Item 2        Changes  in  Securities.

              None

Item 3        Defaults  Upon  Senior  Securities.

              None.

Item 4        Submission of Matters to a Vote of Security Holders

              None.

Item 5        Other  Information.

              None.



          SIGNATURES


In  accordance  with  the  requirements of Section 13 or 15(d) of the Securities
Exchange  Act  of  1934,  the  registrant caused this report to be signed on its
behalf  by  the  undersigned, thereunto duly authorized, in the City of Seattle,
Washington,  on  January  31,  2001.


                                  CARING PRODUCTS INTERNATIONAL, INC.

                                  By:  /s/  Susan  A.  Schreter
                                     --------------------------------
                                     Susan  A.  Schreter
                                     Acting Chairman of the Board and
                                     CEO


In  accordance  with  the requirements of the Exchange Act, this report has been
signed  by  the  following  persons  on  behalf  of  the  registrant  and in the
capacities  and  on  the  dates  indicated:

     SIGNATURE                        TITLE                           DATE
     ---------                        -----                           ----
/s/  Susan A. Schreter        Acting Chairman and CEO          November 11, 2000
----------------------
Susan A. Schreter


9
<PAGE>